Pharmacokinetics of Nuelin-SR 250 mg in asthmatic children: a new sustained-release theophylline.
The pharmacokinetics of Nuelin-SR 250 mg was studied in asthmatic children. This study suggests that this new sustained-release theophylline will be useful for the purpose of maintaining serum theophylline levels within the safe and therapeutic range with a twice daily dosing schedule.
D000293:Adolescent; D001249:Asthma / Q000188:drug therapy*; D002648:Child; D003692:Delayed-Action Preparations; D006801:Humans; D007700:Kinetics; D013806:Theophylline / Q000009:adverse effects / Q000097:blood / Q000378:metabolism*; D013997:Time Factors
D003692:Delayed-Action Preparations; D013806:Theophylline